Investigating new therapies for spinal muscular atrophy
Mechanisms and SMN-Independent Therapies for Spinal Muscular Atrophy
This study is looking at new ways to help people with spinal muscular atrophy (SMA) by exploring treatments that go beyond just fixing the SMN protein, aiming to find better options for young patients with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11059216 on NIH RePORTER |
What this research studies
This research focuses on understanding the mechanisms behind spinal muscular atrophy (SMA), a severe neuromuscular disorder caused by mutations in the SMN1 gene. The project aims to explore therapies that do not rely solely on the SMN protein, including small molecule modulators and viral vector approaches to restore SMN levels. By studying the underlying causes of SMA, the research seeks to improve treatment strategies and outcomes for affected individuals, particularly those diagnosed at a young age.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants and young children diagnosed with spinal muscular atrophy, particularly those under the age of two.
Not a fit: Patients with spinal muscular atrophy who are older or have already progressed to advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for spinal muscular atrophy, potentially improving survival and quality of life for patients.
How similar studies have performed: Previous research has shown promise in targeting the SMN2 gene for SMA treatment, indicating that exploring alternative therapies could also yield beneficial results.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Monani, Umrao — Columbia University Health Sciences
- Study coordinator: Monani, Umrao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.